Investigators compared outcomes of intrathoracic vs cervical anastomosis following transthoracic minimally invasive esophagectomy.
Investigators aimed to determine optimal chemotherapy dosing for older, frail patients with gastroesophageal cancer and use of geriatric assessment as a decision making tool.
Investigators aimed to determine the ideal age to discontinue surveillance in patients with non-dysplastic Barrett esophagus based on sex and comorbidities.
Investigators sought to evaluate the relationship between Hill grade confirmed with EGD and the degree of gastroesophageal reflux in children with GERD.
Researchers investigated whether varicella zoster virus is linked to achalasia.
Researchers reviewed the current status of and advances in the detection of Barrett esophagus and risks for esophageal adenocarcinoma.
Etrasimod is an investigational, next generation, once-daily, oral, highly selective sphingosine 1-phosphate receptor modulator.
The approval was based on data from the phase 3 CheckMate-577 trial which included 794 adults with completely resected esophageal or GEJ cancer who had residual pathologic disease following neoadjuvant CRT.
Approximately one-sixth of patients with obstructive sleep apnea (OSA) have demonstrated symptoms of dysphagia.
The accelerated approval was based on data from the KEYNOTE-811 study.
Investigators examined short-term and long-term outcomes of patients treated for BE with dysplasia and/or early cancer, according to a uniform protocol.
Investigators compared the use of linked color imaging vs high-definition white light endoscopy for detection of polyps in patients with Lynch syndrome.
Residual pathologic disease often remains after neoadjuvant chemotherapy and resection in patients with esophageal or GEJ cancers, and these patients have a high risk of recurrence.
Opdivo (nivolumab) is now approved for the treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma.
Opdivo is a programmed death receptor-1 (PD-1)-blocking antibody.
Researchers compared safety and long-term survival of nCRT followed by MIE vs nCT followed by MIE in patients with advanced ESCC.
Researchers aimed to confirm the results of two previous RCTs comparing the effectiveness of radiofrequency ablation vs surveillance in patients with Barrett Oesophagus.
Investigators examined the effectiveness of the PARP inhibitor olaparib in patients with pancreatic cancer with BRCAness.
Researchers presented a case series for the use of endoscopic delivery of stromal vascular fraction obtained by mechanical emulsification of autologous adipose tissue in patients with upper GI tract fistulas.
Investigators explored the mechanism by which solid tumors appear to resist immune checkpoint inhibitor therapies.